The advent of bright X-ray light sources such as third-generation synchrotrons and X ray free electron lasers has resulted in the emergence of time-resolved serial crystallography. These novel serial crystallography methods were combined with time resolved spectroscopy and hybrid quantum mechanics/molecular mechanics simulations to study conformational changes and chloride translocation in NmHR after photoactivation. Five active state structural intermediates, determined in the picosecond to microsecond time domain, have been determined at the X-ray free electron laser. Structural insight into the late photocycle of NmHR was provided by time-resolved serial crystallography at the synchrotron, resulting in ten additional active state intermediates in the millisecond time domain. In addition, a new method was developed that allowed tracing of the anomalous substructure in the photostationary state, providing critical clues on the anion transport pathway in NmHR.
Together with resolving the position of four new transient chloride binding sites in time, the mechanism driving chloride transport is proposed based on the observed conformational changes of the protein after photoactivation. In summary, in the resting state chloride interacts with the protonated Schiff base of the retinal chromophore. Upon absorption of a photon, the retinal chromophore then isomerizes from the all trans to 13-cis configuration, which flips the protonated Schiff base and disrupts the interaction with the chloride ion. In the following step, the chloride translocation is initiated as the anion is pulled over the retinal chromophore to reestablish the interaction with the positive charge on the protonated Schiff base. After chloride is released into the exit tunnel to further diffuse towards the cytoplasm, a steric gate prevents chloride from flowing back into the dark state binding site. At the same time as the release of the chloride ion into the cytoplasm, a new anion is taken up from the extracellular space. In the uptake tunnel, the anion encounters a bottleneck formed by a salt bridge between an arginine and aspartate residue which forms an electrostatic gate. Upon opening of this electrostatic gate, chloride can enter the retinal binding pocket, a hydrophilic cavity in which the dark state binding site is located. Together with the closure of the electrostatic gate, the retinal chromophore isomerizes back to the all-trans-configuration, and the dark state chloride binding site is regenerated.
This thesis thereby presents the first detailed structural dynamics of ion transport by a chloride pumping rhodopsin and demonstrates the capabilities of novel serial crystallography methods. Less
methods, which serve as a foundation for structural biology and account for nearly 90% of the more than 165,000
biomolecular structures available in the PDB. Crystallography requires high-quality, well-diffracting crystals;
coaxing biomolecules into crystalline form is a rate-limiting step in structure determination. Searching for
conditions in which a biomolecule will crystallize often entails screening multiple different constructs against
thousands of crystallization conditions, requiring large sample amounts and many person-hours in a typical
laboratory set-up. In recent circumstances due to the COVID-19 pandemic, being physically in the laboratory for
setting up crystallization screening has become even more difficult. The Crystallization Center at HWI has been in
continuous operation as a crystallization resource for 20 years providing mail-in crystallization and remote access
to crystal growth monitoring. These services have become even more critical in the face of restrictions due to
COVID-19. The Crystallization Center is a high-throughput facility that provides expertise and access to state-ofthe-
art instrumentation to facilitate efficient and cost-effective crystallization. We have extensive robotics for
automated sample handling with very small sample volumes integrated with advanced imaging and a Formulatrix
Rock Imager with SONICC for rapid detection of crystal growth. The current pipeline in the Crystallization Center
screens for 1,536 conditions in one experimental plate and employs a robust imaging schedule, all of which is then
accessible remotely. Here, we will present details about the current capacity for high-throughput crystal growth
screening. We will also discuss innovations we are developing and opportunities for enhanced crystallization
services that will further facilitate crystallization for biomolecular structure determination, including scale up and
optimization, in situ diffraction experiments and enhanced imaging for crystal detection. Less